Updated Strategies for Pulse Oximetry Screening for Critical Congenital Heart Disease
- PMID: 32499387
- DOI: 10.1542/peds.2019-1650
Updated Strategies for Pulse Oximetry Screening for Critical Congenital Heart Disease
Abstract
Seven years after its addition to the US Recommended Uniform Screening Panel, newborn screening for critical congenital heart disease (CCHD) using pulse oximetry became mandatory in the United States. Although CCHD newborn screening reduces morbidity and mortality, there remain important opportunities to improve. An expert panel convened for a 1-day meeting in September 2018, including subject matter experts and representatives from stakeholder organizations. Presentations on CCHD outcomes, variations in approach to screening, and data and quality improvement helped identify improvement opportunities. The expert panel concluded that sufficient evidence exists to recommend modifying the current American Academy of Pediatrics algorithm by (1) requiring an oxygen saturation of at least 95% in both (formerly either) the upper and lower extremities to pass and (2) requiring only 1 repeat screen instead of 2 for cases that neither pass nor fail initially. The panel underscored the importance of improving public health reporting by further specifying the targets of screening and criteria for reporting outcomes (false-negative and false-positive cases). The panel also highlighted the need to ensure sufficient public health funding for CCHD newborn screening and opportunities for education and global implementation. Newborn screening for CCHD using pulse oximetry has led to significant improvements in child health outcomes. However, further important work is required to understand and improve the effectiveness and efficiency of screening.
Copyright © 2019 by the American Academy of Pediatrics.
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
Similar articles
-
A Modified Algorithm for Critical Congenital Heart Disease Screening Using Pulse Oximetry.Pediatrics. 2018 May;141(5):e20174065. doi: 10.1542/peds.2017-4065. Pediatrics. 2018. PMID: 29691284
-
Newborn Critical Congenital Heart Disease Screening Using Pulse Oximetry: Nursing Aspects.Am J Perinatol. 2016 Sep;33(11):1072-5. doi: 10.1055/s-0036-1586108. Epub 2016 Sep 7. Am J Perinatol. 2016. PMID: 27603538 Review.
-
Screening for Critical Congenital Heart Disease.Clin Perinatol. 2016 Mar;43(1):73-80. doi: 10.1016/j.clp.2015.11.005. Clin Perinatol. 2016. PMID: 26876122 Review.
-
Implications of Using Pulse Oximetry to Screen for Critical Congenital Heart Disease in Newborns.Nurs Womens Health. 2015 Aug-Sep;19(4):314-23. doi: 10.1111/1751-486X.12217. Nurs Womens Health. 2015. PMID: 26264796
-
False-negative pulse oximetry screening for critical congenital heart disease: the case for parent education.Pediatr Cardiol. 2013 Oct;34(7):1736-8. doi: 10.1007/s00246-012-0414-5. Epub 2012 Jul 12. Pediatr Cardiol. 2013. PMID: 22790314
Cited by
-
Cost-utility analysis of prenatal diagnosis of congenital cardiac diseases using deep learning.Cost Eff Resour Alloc. 2024 May 22;22(1):44. doi: 10.1186/s12962-024-00550-3. Cost Eff Resour Alloc. 2024. PMID: 38773527 Free PMC article.
-
Home Pulse Oximetry Monitoring during the COVID-19 Pandemic: An Assessment of Patient Engagement and Compliance.Health Policy Technol. 2023 Jun 26:100776. doi: 10.1016/j.hlpt.2023.100776. Online ahead of print. Health Policy Technol. 2023. PMID: 38620095 Free PMC article.
-
Pulse oximetry test for screening congenital heart diseases: a systematic review.Rev Esc Enferm USP. 2024 Mar 1;57:e20230215. doi: 10.1590/1980-220X-REEUSP-2023-0215en. eCollection 2024. Rev Esc Enferm USP. 2024. PMID: 38426937 Free PMC article.
-
A new algorithm DEtectS critical Congenital Heart Disease at different altitudes: ANDES-CHD study.J Perinatol. 2024 Mar;44(3):373-378. doi: 10.1038/s41372-024-01888-5. Epub 2024 Feb 2. J Perinatol. 2024. PMID: 38308011
-
[The adult with tetralogy of fallot: what the clinical cardiologist needs to know].Arch Peru Cardiol Cir Cardiovasc. 2021 Jun 30;2(2):121-129. doi: 10.47487/apcyccv.v2i2.138. eCollection 2021 Apr-Jun. Arch Peru Cardiol Cir Cardiovasc. 2021. PMID: 38274563 Free PMC article. Review. Spanish.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical